LOADING
Tag: Wire
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older – Business Wire
March 9, 2025
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
chat_bubble0 Comment
visibility208 Views
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) – Business Wire
February 27, 2025
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) Business Wire Source link
chat_bubble0 Comment
visibility182 Views